AKTIEN IM FOKUS: Übernahme von Aetna setzen CVS-Health-Aktien unter Druck (Seite 8) | Diskussion im Forum
eröffnet am 05.03.18 21:49:56 von
neuester Beitrag 01.06.24 11:33:22 von
neuester Beitrag 01.06.24 11:33:22 von
Beiträge: 93
ID: 1.275.619
ID: 1.275.619
Aufrufe heute: 33
Gesamt: 10.066
Gesamt: 10.066
Aktive User: 0
ISIN: US1266501006 · WKN: 859034 · Symbol: CVS
54,93
EUR
+6,12 %
+3,17 EUR
Letzter Kurs 31.05.24 Tradegate
Neuigkeiten
| TitelBeiträge |
|---|
19.05.24 · wallstreetONLINE Redaktion |
10.05.24 · Business Wire (engl.)  |
03.05.24 · Business Wire (engl.) |
03.05.24 · Business Wire (engl.) |
Werte aus der Branche Einzelhandel
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 9,0300 | +349,25 | |
| 0,8700 | +35,94 | |
| 67,95 | +30,55 | |
| 0,6700 | +13,56 | |
| 1,8320 | +11,30 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 6,7000 | -16,25 | |
| 2,4400 | -16,44 | |
| 3,2200 | -18,27 | |
| 2,0000 | -20,00 | |
| 15,900 | -23,96 |
Beitrag zu dieser Diskussion schreiben
FeedbackFantastische Aussichten
Die planen den Verkauf von cannabisprodukte in acht Bundesstaaten.https://www.wallstreet-online.de/nachricht/11328933-top-news… insgesamt hat CVS 500 Apotheken. Ich glaube damit ist alles gesagt um sich dieses WERTpapier ins Depot zu legen. Das wird uns noch sehr viel Freude bereiten nun auch hier mit Cannabis
Größte Apotheken-Kette der USA steigt ins Cannabis-Geschäft ein https://www.wallstreet-online.de/nachricht/11326422-s-p-500-…
=>
...CVS Pharmacy, mit mehr als 9.800 Filialen die größte Apotheken-Kette der USA, steigt ins Cannabis-Geschäft ein.
In US-Bundesstaaten, in denen Cannabis legalisiert wurde, wird die Apotheken-Kette ab sofort Produkte mit dem nicht-psychoaktiven Hanf-Inhaltsstoff Cannabidiol (CBD) verkaufen.
Dies berichtet der US-Nachrichtensender "CNBC". Die Apotheken-Kette erklärte, dass sie auf CBD-basierte Salben, Cremes, Sprays, Roll-ons und Lotionen im Programm hat. Diese Produkte sind in CVS-Apotheken in acht US-Bundesstaaten erhältlich: Alabama, Kalifornien, Colorado, Illinois, Indiana, Kentucky, Maryland und Tennessee.
CVS Pharmacy ist eine Unternehmenstochter von CVS Health, ein im S&P 500 gelistetes Unternehmen. CVS erklärte, dass sie keine CBD-haltigen Lebensmittelzusatzstoffe oder Nahrungsergänzungsmittel verkaufen wird.
In einer Pressemitteilung des Konzerns heißt es: "Wir sind eine Partnerschaft mit CBD-Produzenten eingegangen, die die geltenden Gesetze einhalten und die die hohen Qualitätsstandards von CVS erfüllen"...
CVS hat charttechnisch alle Widerstände nach unten durchbrochen. Letzter Widerstand 57 USD
Mal sehen wo die Haltelinie ist. Sollte es auf das Kursniveau von 46 USD gehen, pendeln wir wieder in der Preisrange von 2012.
Mal sehen wo die Haltelinie ist. Sollte es auf das Kursniveau von 46 USD gehen, pendeln wir wieder in der Preisrange von 2012.
Antwort auf Beitrag Nr.: 59.884.573 von faultcode am 15.02.19 15:49:35aus der 2018Q4-Präsi:
Balancing Near-term Execution with Long-term Vision: The Challenges in 2019
• Ongoing pharmacy reimbursement pressures in our businesses and reduction in offsets to those pressures, including a declining benefit from generics
• Lower brand inflation and ongoing questions around rebates
• Structural and CVS-specific challenges in long-term care space
These challenges are having a disproportionate impact compared to prior years
=> daher die Ernüchterung gestern mit -8% =>
Balancing Near-term Execution with Long-term Vision: The Challenges in 2019
• Ongoing pharmacy reimbursement pressures in our businesses and reduction in offsets to those pressures, including a declining benefit from generics
• Lower brand inflation and ongoing questions around rebates
• Structural and CVS-specific challenges in long-term care space
These challenges are having a disproportionate impact compared to prior years
=> daher die Ernüchterung gestern mit -8% =>
Antwort auf Beitrag Nr.: 59.661.401 von faultcode am 18.01.19 12:58:46auch so'n Ober-Aktienrückkäufer - eine Seuche:
Trading Spotlight
Antwort auf Beitrag Nr.: 59.360.066 von faultcode am 04.12.18 15:19:34
https://www.marketwatch.com/story/cvss-stock-jumps-after-dea…
=>
...Shares of CVS Health Corp. rallied 2.6% in premarket trade Friday, after the drugstore chain and Walmart Inc. have reached a multi-year agreement in which Walmart will continue to participate in the CVS Caremark pharmacy benefit management (PBM) retail pharmacy networks.
Walmart shares were still inactive. The companies did not disclose financial terms of the agreement. Earlier this week, CVS said Walmart had decided to leave its PBM networks because of a dispute over pricing. "We are very pleased to have reached a mutually agreeable solution with Walmart. As a PBM, our top priority is to help our clients and consumers lower their pharmacy costs," said CVS Caremark President Derica Rice. "This new agreement accomplishes our top priority and enables Walmart to continue participating in CVS Caremark's commercial and Managed Medicaid pharmacy networks and provides enhanced network stability for our clients and their members."...
CVS's stock jumps after deal to keep Walmart participating in PBM networks
18.1.https://www.marketwatch.com/story/cvss-stock-jumps-after-dea…
=>
...Shares of CVS Health Corp. rallied 2.6% in premarket trade Friday, after the drugstore chain and Walmart Inc. have reached a multi-year agreement in which Walmart will continue to participate in the CVS Caremark pharmacy benefit management (PBM) retail pharmacy networks.
Walmart shares were still inactive. The companies did not disclose financial terms of the agreement. Earlier this week, CVS said Walmart had decided to leave its PBM networks because of a dispute over pricing. "We are very pleased to have reached a mutually agreeable solution with Walmart. As a PBM, our top priority is to help our clients and consumers lower their pharmacy costs," said CVS Caremark President Derica Rice. "This new agreement accomplishes our top priority and enables Walmart to continue participating in CVS Caremark's commercial and Managed Medicaid pharmacy networks and provides enhanced network stability for our clients and their members."...
Antwort auf Beitrag Nr.: 59.148.543 von faultcode am 06.11.18 13:51:35
=>
...WASHINGTON — A federal judge on Monday sharply questioned the Justice Department’s decision to green-light CVS Health Corp.’s nearly $70 billion acquisition of Aetna Inc. , and said he may order CVS to halt its integration of Aetna’s assets while he considers the merger’s implications.
It is highly unusual for a judge to make such an announcement, since Justice Department antitrust enforcers had approved the deal in October under the condition the companies sell Aetna’s Medicare drug business to preserve competition. The companies sold those assets to WellCare Health Plans Inc.
When the Justice Department identifies concerns with a merger — and reaches an agreement with the merging companies to address them — a federal law called the Tunney Act requires the government to file the proposed settlement for approval by a federal court, which determines whether the deal is in the public interest.
Such settlements are almost universally approved, often without a judge calling a hearing. But U.S. District Judge Richard Leon — who was a central figure in AT&T Inc.’s merger with Time Warner Inc. — made clear he would play an active role.
He said at a terse hearing Monday — in which he sought no input from either the Justice Department or the companies — that he was concerned that the department hadn’t adequately addressed the potential competitive harms raised by the merger.
=> Aktie eigentlich ungerührt
WSJ: Judge questions CVS-Aetna merger, says he may halt asset integration
https://www.marketwatch.com/story/judge-questions-cvs-aetna-…=>
...WASHINGTON — A federal judge on Monday sharply questioned the Justice Department’s decision to green-light CVS Health Corp.’s nearly $70 billion acquisition of Aetna Inc. , and said he may order CVS to halt its integration of Aetna’s assets while he considers the merger’s implications.
It is highly unusual for a judge to make such an announcement, since Justice Department antitrust enforcers had approved the deal in October under the condition the companies sell Aetna’s Medicare drug business to preserve competition. The companies sold those assets to WellCare Health Plans Inc.
When the Justice Department identifies concerns with a merger — and reaches an agreement with the merging companies to address them — a federal law called the Tunney Act requires the government to file the proposed settlement for approval by a federal court, which determines whether the deal is in the public interest.
Such settlements are almost universally approved, often without a judge calling a hearing. But U.S. District Judge Richard Leon — who was a central figure in AT&T Inc.’s merger with Time Warner Inc. — made clear he would play an active role.
He said at a terse hearing Monday — in which he sought no input from either the Justice Department or the companies — that he was concerned that the department hadn’t adequately addressed the potential competitive harms raised by the merger.
=> Aktie eigentlich ungerührt
Antwort auf Beitrag Nr.: 58.918.755 von faultcode am 10.10.18 17:07:02
https://www.marketwatch.com/story/cvs-shares-rise-after-earn…
=>
CVS Health Corp. shares rose 2.6% in Tuesday premarket trading after the pharmacy retailer reported third-quarter earnings and sales that beat consensus.
Net income totaled $1.39 billion, or $1.36 per share, up from $1.29 billion, or $1.26 per share, last year.
Adjusted EPS was $1.73. Revenue totaled $47.3 billion, up from $46.2 billion. And same-store sales rose 6.7% with pharmacy same-store sales up 8.7%.
The FactSet consensus was for EPS of $1.71, revenue of $47.2 billion, and same-store sales growth of 5.4%.
Pharmacy same-store sales were forecast to be up 7.6%.
CVS continues to expect full-year EPS of $1.40 to $1.50 and adjusted EPS of $6.98 to $7.08. The FactSet guidance is for EPS of $7.04....
=> P/E|2018e = ~USD76 / USD7.04 = ~10.8 --> nicht sehr teuer würde ich mal sagen
CVS shares rise after earnings and sales beat consensus
Published: Nov 6, 2018 7:14 a.m. EThttps://www.marketwatch.com/story/cvs-shares-rise-after-earn…
=>
CVS Health Corp. shares rose 2.6% in Tuesday premarket trading after the pharmacy retailer reported third-quarter earnings and sales that beat consensus.
Net income totaled $1.39 billion, or $1.36 per share, up from $1.29 billion, or $1.26 per share, last year.
Adjusted EPS was $1.73. Revenue totaled $47.3 billion, up from $46.2 billion. And same-store sales rose 6.7% with pharmacy same-store sales up 8.7%.
The FactSet consensus was for EPS of $1.71, revenue of $47.2 billion, and same-store sales growth of 5.4%.
Pharmacy same-store sales were forecast to be up 7.6%.
CVS continues to expect full-year EPS of $1.40 to $1.50 and adjusted EPS of $6.98 to $7.08. The FactSet guidance is for EPS of $7.04....
=> P/E|2018e = ~USD76 / USD7.04 = ~10.8 --> nicht sehr teuer würde ich mal sagen
Antwort auf Beitrag Nr.: 58.632.165 von faultcode am 06.09.18 15:13:18--> nun ist es fast geschafft:
10.10.
DOJ approves CVS-Aetna merger as long as prescription drug business sold to WellCare
https://www.marketwatch.com/story/doj-approves-cvs-aetna-mer…
=>...
The Justice Department said Wednesday that CVS Health and Aetna will have to divest Aetna's Medicare Part D prescription drug plan business to proceed with its merger.
The proposed divestiture to WellCare Health Plans, Inc. would fully resolve the Justice Department's competition concerns, the agency said.
=> CVS zuletzt:
10.10.
DOJ approves CVS-Aetna merger as long as prescription drug business sold to WellCare
https://www.marketwatch.com/story/doj-approves-cvs-aetna-mer…
=>...
The Justice Department said Wednesday that CVS Health and Aetna will have to divest Aetna's Medicare Part D prescription drug plan business to proceed with its merger.
The proposed divestiture to WellCare Health Plans, Inc. would fully resolve the Justice Department's competition concerns, the agency said.
=> CVS zuletzt:
Durchsuchen
19.05.24 · wallstreetONLINE Redaktion · Amazon |
02.05.24 · wO Chartvergleich · Ansys |
01.05.24 · wallstreetONLINE Redaktion · CVS Health |
01.05.24 · dpa-AFX · Advanced Micro Devices |
23.04.24 · Aktienwelt360 · Chevron Corporation |
16.04.24 · dpa-AFX · CVS Health |